Centre Places Urgent Orders For 11.45 Cr HCQ Tablets
The Central government has placed urgent orders for 11.45 crore tablets of the anti-malarial drug hydroxychloroquine.
According to the news agency ANI, this order has been placed with two Indian companies - Ipca and Cadila.
So far, a consignment of 6.64 crore tablets has been delivered to the Health Ministry and the remaining tablets will reach there by May 16. The anti-malarial drug hydroxychloroquine is effective in combating the coronavirus pandemic. It is usually administered to frontline health workers in cases of emergency. Citing the Health Ministry, ANI has written that out of the 6.4 crore tablets received so far, while 4.3 crore tablets have been distributed among various states in the country, the remaining tablets are in the buffer stock. Apart from this, several states have purchased 3.8 crore tablets directly from pharma companies. On Friday, the Central government informed that the country’s capacity to produce hydroxychloroquine tablets has been ramped up. While 30 crore tablets were produced in April, this capacity was 12.33 crore earlier. Hydroxychloroquine is the same medicine the export of which had been banned by the Central government. However, this restriction was lifted after the United States exerted pressure on the government of India. Soon after, the Central government had sent 30 lakh hydroxychloroquine tablets to 87 countries, including the US. Watch the video story here:
So far, a consignment of 6.64 crore tablets has been delivered to the Health Ministry and the remaining tablets will reach there by May 16. The anti-malarial drug hydroxychloroquine is effective in combating the coronavirus pandemic. It is usually administered to frontline health workers in cases of emergency. Citing the Health Ministry, ANI has written that out of the 6.4 crore tablets received so far, while 4.3 crore tablets have been distributed among various states in the country, the remaining tablets are in the buffer stock. Apart from this, several states have purchased 3.8 crore tablets directly from pharma companies. On Friday, the Central government informed that the country’s capacity to produce hydroxychloroquine tablets has been ramped up. While 30 crore tablets were produced in April, this capacity was 12.33 crore earlier. Hydroxychloroquine is the same medicine the export of which had been banned by the Central government. However, this restriction was lifted after the United States exerted pressure on the government of India. Soon after, the Central government had sent 30 lakh hydroxychloroquine tablets to 87 countries, including the US. Watch the video story here:
Latest Videos
